AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare AirSculpt Technologies to similar businesses based on the strength of its profitability, risk, institutional ownership, analyst recommendations, valuation, dividends and earnings.
Risk & Volatility
AirSculpt Technologies has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500. Comparatively, AirSculpt Technologies’ rivals have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and price targets for AirSculpt Technologies and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AirSculpt Technologies | 1 | 0 | 1 | 0 | 2.00 |
| AirSculpt Technologies Competitors | 1890 | 7763 | 13430 | 841 | 2.55 |
AirSculpt Technologies presently has a consensus price target of $2.75, indicating a potential upside of 365.55%. As a group, “Healthcare Providers & Services” companies have a potential upside of 21.91%. Given AirSculpt Technologies’ higher probable upside, research analysts clearly believe AirSculpt Technologies is more favorable than its rivals.
Valuation & Earnings
This table compares AirSculpt Technologies and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| AirSculpt Technologies | $147.68 million | -$11.67 million | -4.54 |
| AirSculpt Technologies Competitors | $19.23 billion | $301.67 million | -3.54 |
AirSculpt Technologies’ rivals have higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Insider & Institutional Ownership
91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares AirSculpt Technologies and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AirSculpt Technologies | -6.36% | -9.43% | -4.94% |
| AirSculpt Technologies Competitors | -1.05% | -139.10% | -2.48% |
Summary
AirSculpt Technologies rivals beat AirSculpt Technologies on 8 of the 13 factors compared.
About AirSculpt Technologies
AirSculpt Technologies, Inc. provides elective body-contouring and aesthetic procedures through its Elite Body Sculpture centers. Its services include fat removal and fat transfer, using its branded AirSculpt technique, which is designed to remove fat through small entry points without traditional liposuction incisions. The company’s offerings also include procedures that use a patient’s own fat to enhance or reshape areas of the body. AirSculpt Technologies serves patients through centers in the United States and Canada.
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
